The switch from a pro-inflammatory to an anti-inflammatory immune response in Mif−/− or anti-MIF IgG treated WT mice during the chronic stage of infection was reflected by a reduction in pathogenicity, as evidenced by less liver damage and anemia, which are the main pathogenic manifestations of T. brucei infection [3], [7]. The gene discussed is MIF; the disease is anemia.